Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03727490 · ClinicalTrials.gov registry record · NA

The Role of Subscapularis Repair in Reverse Shoulder Arthroplasty

A NA study, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
102
Enrollment target

NCT03727490 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 102 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03727490, a NA study, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
102 participants
Enrollment target

Study Summary

The overall goal of the study is to determine if repairing the subscapularis tendon during primary reverse shoulder arthroplasty effects short-term patient outcomes. The study is a patient blinded randomized controlled trial that is currently enrolling.

Interventions

  • OTHER Standard Treatment
  • OTHER Repair

Trial Details

FieldValue
Enrollment Target 102 participants
Start Date 2018-12-01
Est. Completion 2025-05-31
Phase NA

What the Registry Record Tells You About NCT03727490

The ClinicalTrials.gov registry entry for NCT03727490 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Standard Treatment is the first listed.

NCT03727490 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03727490 about?

NCT03727490 is a clinical study titled "The Role of Subscapularis Repair in Reverse Shoulder Arthroplasty". The overall goal of the study is to determine if repairing the subscapularis tendon during primary reverse shoulder arthroplasty effects short-term patient outcomes. The study is a patient blinded randomized controlled trial that is currently enrolling.

What is the current status of trial NCT03727490?

This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2018-12-01. Estimated completion is 2025-05-31.

What interventions are being tested in trial NCT03727490?

The interventions under investigation include: Standard Treatment (OTHER), Repair (OTHER).

Who is sponsoring clinical trial NCT03727490?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.